Jean-Philippe Stéphan

Author

Also Known As

J P Stéphan, J. P. Stéphan, J. STEPHAN, J.-P. Stephan, J.P. Stephan, JP Stephan, Jean-Philippe Stephan, Jean-Philippe Stéphan, Jean‐Philippe Stephan, L. Haeberle

119

Publications

3.9K

Citations

H-Index

101

Concepts

All Affiliations

Molecular Oncology (United States)Sunesis (United States)Université de Rennes Inserm Genentech

About

Jean-Philippe Stéphan is an author at Molecular Oncology (United States) specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	25	3.3K
2	Engineering	2	2	274
3	Natural Sciences	2	2	72
4	Allergy	2	2	534
5	Biochemistry	2	2	73

Jean-Philippe Stéphan

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
A Mouse Model of Hepatocellular Carcinoma Katrina Nicholes, Susan Guillet, Elizabeth Tomlinson, American Journal Of Pathology HepatologyLiver PhysiologyPathologyLiver CancerMedicine	2002	348
A Two-in-One Antibody against HER3 and EGFR Has Superior Inhibitory Activity Compared with Monospecific Antibodies Gabriele Schaefer, Lauric Haber, Lisa Crocker, Cancer Cell Immunocytochemical TechniqueAllergyAutoimmune DiseaseImmunologyAntibody Screening	2011	332
Repression of Stress-Induced LINE-1 Expression Protects Cancer Cell Subpopulations from Lethal Drug Exposure Gulfem D. Guler, Charles Tindell, Robert Pitti, Cancer Cell Cell RegulationOncogenic AgentMedicineCell DeathLethal Drug Exposure	2017	255
Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice Jing Qing, Xiangnan Du, Yongmei Chen, Journal of Clinical Investigation Bladder CarcinomaFgf Receptor 3Genitourinary CancerMedicineImmunology	2009	252
Antibody-Drug Conjugates for the Treatment of Non–Hodgkin's Lymphoma: Target and Linker-Drug Selection Andrew G. Polson, Jill Calemine-Fenaux, Pamela Chan, Cancer Research ImmunologyChemical LinkersImmunotherapeuticsImmunotherapyTumor Biology	2009	247
Antibodies against the gH/gL/UL128/UL130/UL131 Complex Comprise the Majority of the Anti-Cytomegalovirus (Anti-CMV) Neutralizing Antibody Response in CMV Hyperimmune Globulin Ashley E. Fouts, Pamela Chan, Jean-Philippe Stéphan, Journal of Virology HistocompatibilityViral PathogenesisImmunologyAntigen ProcessingImmunotherapy	2012	202
Production, characterization and pharmacokinetic properties of antibodies with N-linked Mannose-5 glycans Marcella Yu, Darren L. Brown, Chae Reed, mAbs N-linked Mannose-5 GlycansImmunologyGlycobiologyImmunodominanceHomogeneous Antibodies	2012	202
An Integrated Genomic Screen Identifies LDHB as an Essential Gene for Triple-Negative Breast Cancer Mark L. McCleland, Adam S. Adler, Yonglei Shang, Cancer Research Systems BiologyOncologyEngineeringEndocrine-related CancerBreast Oncology	2012	195
Antibody-drug conjugates targeted to CD79 for the treatment of non-Hodgkin lymphoma Andrew G. Polson, Shang‐Fan Yu, Kristi Elkins, Blood	2007	168
TRAF2 Sets a Threshold for Extrinsic Apoptosis by Tagging Caspase-8 with a Ubiquitin Shutoff Timer François Gonzalvez, David A. Lawrence, Becky Yang, Molecular Cell Signal TransductionUbiquitin Shutoff TimerSignaling PathwayReceptor Tyrosine KinaseApoptosis	2012	164

Page 1